Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors

被引：1

作者：

Janssen, Josephine C. ^{[1
,2
]}

Huibers, Anne E. ^{[3
,4
]}

Grunhagen, Dirk J. ^{[1
]}

Bagge, Roger Olofsson ^{[3
,4
]}

机构：

[1] Erasmus MC Canc Inst, Dept Surg Oncol & Gastrointestinal Surg, Rotterdam, Netherlands

[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands

[3] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Surg, Gothenburg, Sweden

[4] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden

来源：

SCANDINAVIAN JOURNAL OF SURGERY | 2025年

关键词：

Metastasectomy; metastatic melanoma; immune checkpoint inhibitors; MALIGNANT-MELANOMA; THERAPY; ADJUVANT; DISEASE;

D O I：

10.1177/14574969251331663

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Surgery has historically played a pivotal role in the management of metastatic melanoma, evolving significantly with the advances of systemic therapies. The advent of immune checkpoint inhibitors initially diminished the role of surgery in treatment paradigms; however, there has been a resurgence of interest in its application within this setting. Several retrospective studies show a survival benefit for patients treated with immune checkpoint inhibitors who are resected to no evidence of disease, especially in case of an objective response to modern therapies. This narrative review explores the role of surgery as a treatment modality in metastatic melanoma before and in the era of immune checkpoint inhibitors, highlighting indications, outcomes, and integration with systemic treatment approaches.

引用

页数：6

共 50 条

[31] Immune Checkpoint Blockade in Patients With Melanoma Metastatic to the Brain [J].

Di Giacomo, Anna Maria ;

Margolin, Kim .

SEMINARS IN ONCOLOGY, 2015, 42 (03) :459-465

[32] Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors [J].

T. Gambichler ;

C. Finis ;

N. Abu Rached ;

C. H. Scheel ;

J. C. Becker ;

K. Lang ;

H. U. Käfferlein ;

T. Brüning ;

N. Abolmaali ;

L. Susok .

Journal of Cancer Research and Clinical Oncology, 2023, 149 :1241-1247

[33] Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors [J].

Gault, A. ;

Anderson, A. E. ;

Plummer, R. ;

Stewart, C. ;

Pratt, A. G. ;

Rajan, N. .

BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) :263-271

[34] Association of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors [J].

Howell, Ashley, V ;

Gebregziabher, Mulugeta ;

Thiers, Bruce H. ;

Graboyes, Evan M. ;

Paulos, Chrystal M. ;

Wrangle, John M. ;

Hunt, Kelly J. ;

Wallace, Kristin .

JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) :1003-1010

[35] Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors [J].

Gambichler, T. ;

Finis, C. ;

Abu Rached, N. ;

Scheel, C. H. ;

Becker, J. C. ;

Lang, K. ;

Kafferlein, H. U. ;

Bruning, T. ;

Abolmaali, N. ;

Susok, L. .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) :1241-1247

[36] A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors [J].

van Not, Olivier J. ;

Wind, Thijs T. ;

Ismail, Rawa K. ;

Bhattacharya, Arkajyoti ;

Jalving, Mathilde ;

Blank, Christian U. ;

Aarts, Maureen J. B. ;

van den Berkmortel, Franchette W. P. J. ;

Boers-Sonderen, Marye J. ;

van den Eertwegh, Alfonsus J. M. ;

de Groot, Jan Willem B. ;

Haanen, John B. ;

Kapiteijn, Ellen ;

Bloem, Manja ;

Piersma, Djura ;

van Rijn, Rozemarijn S. ;

Stevense-den Boer, Marion ;

van der Veldt, Astrid A. M. ;

Vreugdenhil, Gerard ;

Wouters, Michel W. J. M. ;

Blokx, Willeke A. M. ;

Suijkerbuijk, Karijn P. M. ;

Fehrmann, Rudolf S. N. ;

Hospers, Geke A. P. .

CANCERS, 2023, 15 (11)

[37] Melanoma and Immune Checkpoint Inhibitors [J].

Masutaka Furue ;

Takamichi Ito ;

Naoko Wada ;

Maiko Wada ;

Takafumi Kadono ;

Hiroshi Uchi .

Current Oncology Reports, 2018, 20

[38] Immune checkpoint inhibitors in melanoma [J].

Carlino, Matteo S. ;

Larkin, James ;

Long, Georgina V. .

LANCET, 2021, 398 (10304) :1002-1014

[39] An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors [J].

O'Reilly, Aine ;

Hughes, Peta ;

Mann, Jasmine ;

Lai, Zhuangming ;

Teh, Jhia Jiat ;

Mclean, Emma ;

Edmonds, Kim ;

Lingard, Karla ;

Chauhan, Dharmisha ;

Lynch, Joanna ;

Au, Lewis ;

Ludlow, Aileen ;

Pattison, Natalie ;

Wiseman, Theresa ;

Turajlic, Samra ;

Gore, Martin ;

Larkin, James ;

Husson, Olga .

SUPPORTIVE CARE IN CANCER, 2020, 28 (02) :561-570

[40] An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors [J].

Aine O’Reilly ;

Peta Hughes ;

Jasmine Mann ;

Zhuangming Lai ;

Jhia Jiat Teh ;

Emma Mclean ;

Kim Edmonds ;

Karla Lingard ;

Dharmisha Chauhan ;

Joanna Lynch ;

Lewis Au ;

Aileen Ludlow ;

Natalie Pattison ;

Theresa Wiseman ;

Samra Turajlic ;

Martin Gore ;

James Larkin ;

Olga Husson .

Supportive Care in Cancer, 2020, 28 :561-570

← 1 2 3 4 5 →